e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Ventilation inhomogeneity (VI) and spirometry in response to intravenous antibiotics (IVab) in cystic fibrosis (CF)
N. Al-Khathlan, E. Gaillard, C. Beardsmore (Leicester, United Kingdom; Dammam, Saudi Arabia)
Source:
Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Session:
Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Session type:
Poster Discussion
Number:
3609
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Al-Khathlan, E. Gaillard, C. Beardsmore (Leicester, United Kingdom; Dammam, Saudi Arabia). Ventilation inhomogeneity (VI) and spirometry in response to intravenous antibiotics (IVab) in cystic fibrosis (CF). Eur Respir J 2013; 42: Suppl. 57, 3609
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Related content which might interest you:
Lung clearance index (LCI) and hyperinflation in children with cystic fibrosis (CF)
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012
Sensitivity of N
2
single breath washout (SBW) compared multiple breath washout (MBW) in adults with cystic fibrosis (CF)
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Assessment of the work of breathing (sWOB) within different functional and genetic groups in patients with cystic fibrosis (CF)
Source: Annual Congress 2013 –New perspectives of lung function assessment in children
Year: 2013
Preschool lung clearance index (LCI) predicts adolescent lung function in cystic fibrosis (CF)
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015
Comparison of ventilation heterogeneity (VH) measured with multiple breath washout (MBW) imaging to whole lung MBW LCI and FEV1 in asthma and cystic fibrosis (CF)
Source: International Congress 2015 – Functional imaging approaches for evaluating alteration of lung, airways and respiratory muscles
Year: 2015
Lung Clearance Index (LCI) and FEV
1
on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Lung clearance index (LCI) and trapped gas (TG) may reflect different aspects of Cystic Fibrosis (CF) lung disease in infants
Source: Eur Respir J 2003; 22: Suppl. 45, 228s
Year: 2003
Lung Clearance Index (LCI) derived from N2-Multiple Breath Washout (MBW) depicts worsening in airways colonization in pediatric Cystic Fibrosis (CF) patients (pts)
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020
Validation of nitrogen washout (N2-WO) for measurement of lung clearance index (LCI) and functional residual capacity (FRC) in preschoolers
Source: International Congress 2016 – What's new in paediatric respiratory physiology?
Year: 2016
Breathing pattern during rest and exercise in patients with cystic fibrosis (CF), pulmonary fibrosis (PF) and COPD before lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 685s
Year: 2005
Stable lung function is maintained over 2 years in newborn screened (NBS) CF infants
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013
Longitudinal performance of the bronchiectasis severity index (BSI) in patients on regular intravenous (IV) antibiotic therapy for bronchiectasis
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Nebulised antibiotics with the I-neb adaptive aerosol delivery (AAD) system: Impact on adherence in cystic fibrosis (CF) patients
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012
Adult Cystic Fibrosis (CF) patients prefer to perform impulse oscillometry (IOS) in comparison to spirometry.
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
Ventilation distribution is not influenced by structural lung disease in infants with cystic fibrosis (CF) diagnosed following newborn screening (NBS)
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009
Lung function and early abnormality of glucose tolerance (GT) in cystic fibrosis (CF) patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
High frequency chest wall oscillation (HFCWO) in the treatment of acute pulmonary exacerbation in adult cystic fibrosis (CF) patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Evaluation of the pulmonary function of patients with cystic fibrosis aged 3-18 year old by using impulse oscillometry and spirometry
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015
Effect of positive expiratory pressure (PEP) on breathing pattern characteristics in cystic fibrosis children
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
The oral AntibioticS approprIateness score (OASIS) – A novel scoring system to assess antibiotic route in pulmonary exacerbations of cystic fibrosis (CF)
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept